Air compression massager (ACM-C1, ACM-C2, ACM-C3, ACM-C4, ACM-C5, ACM-C6, ACM-C7, ACM-C8, ACM-C9, ACM-5C1, ACM-5C2, ACM-5C3, ACM-5C4, ACM-5C5, ACM-5C6, ACM-5C7, ACM-5C8, ACM-5C9)
Sichuan Qianli-Beoka Medical Technology, Inc. · Decision date Oct 5, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-05 for 510(k) K262812, submitted 08/07/2026 by Sichuan Qianli-Beoka Medical Technology, Inc. of Chengdu, CN. The device is listed as an air compression massager under the device name covering ACM-C1 through ACM-C9 and ACM-5C1 through ACM-5C9, classified as Massager, Powered Inflatable Tube, regulation 890.5650, product code IRP, in the Physical Medicine specialty and review panel. SESE means clearance to market, not PMA approval.
The record shows a traditional 510(k) not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The listed correspondent is Shenzhen Reanny Medical Devices Management Consulting Co., Ltd. The public page does not state which predicate device was used, what testing supported equivalence, or how the eighteen model designations differ; those details would sit in the underlying 510(k) documents rather than this summary page.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Oct 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262812
- Regulatory pathway
- 510(k) premarket notification
- Product code
- IRP
- Decision code
- SESE
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Massager, Powered Inflatable Tube.
- Product code
- IRP
- FDA device class
- 2
FDA decision timeline
K262812 received
Application receipt date recorded by FDA.
K262812 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IRP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| NormaTec Industries, LP | 510(k) clearance | Oct 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sichuan Qianli-Beoka Medical Technology, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Chengdu
Sources and methodology
- Original FDA record: K262812
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records